Rejected at 4:06 a.m. Dec, 26, 2024 ] by andrewmathias8
Author: jollydolphin
Related Note: 1474340637819
Rationale for change

Use consistent terminology across our notes and prefer the more specific terminology that's used on Amboss.

The wording in the extra of note 1488765287344 tests the general presentation of this complication and states: "Protein C deficiency causes increased risk of warfarin-induced (thrombotic) skin necrosis with hemorrhage after warfarin administration"

Source: AMBOSS - https://next.amboss.com/us/article/Tm06Ug?q=warfarin-induced%20skin%20necrosis#Zcc47c1739f74989df3136377789a6028

Rejection reason

Unnecessary/redundant, esp because warfarin is already mentioned later in the sentence

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::03_Hypercoagulable_Disorders_DDx #AK_Step1_v12::#Pathoma::04_Hemostasis::04_Thrombosis #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants::Extra #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::03_Warfarin #AK_Step2_v12::#FirstAid::07_Hematology::02_Hypercoagulable_States::01_Hypercoagulable_States #AK_Step1_v12::#AMBOSS::Xz09ri #AK_Step1_v12::^Systems::Respiratory::Pathology #PANCE::HEME::coagulation_disorders #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::05_Thrombophilias #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::20_Hereditary_thrombophilias::*Protein_C_S_Deficiency #AK_Step1_v12::#SketchyPath::09_Blood_&_Coagulation::03_Coagulopathies_&_Platelet_Disorders::05_Acquired_&_Inherited_Thrombosis_Syndromes #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::03_Hypercoagulable_States #AK_Step1_v12::#AMBOSS::tQaXB4 #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step1_v12::#UWorld::COMLEX::24199 #AK_Step1_v12::#B&B::04_Biochem::04_Vitamins::03_Other_Vitamins::Extra #AK_Step2_v12::#SketchyIM::01_Cardiology::05_Blood_Vessel_Disease::01_DVT_SOAP #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::03_Hypercoagulable_States #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs::Extra #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::thrombophilia #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::thrombophilia #AK_Step2_v12::#AMBOSS::wx0hAR #AK_Step1_v12::#UWorld::COMLEX::24403 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#UWorld::Step::1088 #AK_Step2_v12::#AMBOSS::9x0NAR #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::10_Thrombophilia #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::^Other::^EXPN::BGedit #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Thrombocytopenia #AK_Step1_v12::^Systems::HemeOnc::Hematology #AK_Step1_v12::#UWorld::Step::1292 #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents